June 2026 in “International Journal of Homoeopathic Sciences” Homeopathic treatment led to significant hair regrowth in a woman with Alopecia totalis.
June 2026 in “British Journal of Dermatology” Hair transplants may trigger frontal fibrosing alopecia.
May 2026 in “Archives of Dermatological Research” Alopecia areata in Asia causes significant hair loss and psychological distress, with high costs and a need for more research.
Telogen hair loss affects emotional well-being and quality of life, with no standard treatment available.
May 2026 in “Jurnal Sehat Indonesia (JUSINDO)” Low vitamin D levels may worsen or cause alopecia areata.
Vitamin D may help improve hair growth in women with diffuse alopecia.
May 2026 in “Institutional Repository of the University of Granada (University of Granada)” New treatments for alopecia areata show promise, but their real-world effectiveness and impact on life and sexual health need more study.
Certain skin and family history markers predict vitiligo severity and treatment needs.
May 2026 in “International Journal of Homoeopathic Sciences” Individualized Homeopathic Medicine shows promise for treating alopecia with lasting hair regrowth.
April 2026 in “Boletín Médico Del Hospital Infantil de México (English Edition)” Most kids with alopecia areata have other health issues, often allergies or skin conditions.
April 2026 in “Zenodo (CERN European Organization for Nuclear Research)” Hair loss is common, with different types affecting people due to genetics, stress, or autoimmune issues.
April 2026 in “Zenodo (CERN European Organization for Nuclear Research)” Hair loss is common and varies by type, with androgenetic alopecia being the most prevalent.
Improving oral health may help hair regrowth in children with alopecia areata.
April 2026 in “International Journal of Drug Delivery Technology” Alopecia can often be managed effectively with various treatments, but early diagnosis is crucial for preventing permanent hair loss.
April 2026 in “The Journal of Dermatology” Vitiligo patients have higher risks of autoimmune diseases, infections, and skin cancer.
April 2026 in “Portuguese Journal of Dermatology and Venereology” COVID-19 and its vaccines can cause various skin issues due to viral effects, immune responses, and stress.
April 2026 in “Zenodo (CERN European Organization for Nuclear Research)” Ayurvedic treatment significantly reduced symptoms of alopecia areata.
April 2026 in “International Journal of Homoeopathic Sciences” Homoeopathic treatment using Opium helped regrow beard hair by addressing mental symptoms.
April 2026 in “Zenodo (CERN European Organization for Nuclear Research)” Ayurvedic treatment significantly reduced alopecia areata symptoms.
April 2026 in “International Journal of Homoeopathic Sciences” Alopecia areata is linked to thyroid diseases, and thyroid testing may help affected patients.
March 2026 in “Immunological Medicine” Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.
March 2026 in “Expert Opinion on Pharmacotherapy” JAK inhibitors are effective for severe alopecia areata but need better strategies for long-term use and personalized treatment.
March 2026 in “International Journal of Innovative Technologies in Social Science” Vitiligo is a systemic disease with psychological effects, and new treatments focus on personalized care.
Customized dermatological treatments effectively address gaps in standard products, especially for complex cases.
March 2026 in “Tạp chí Da liễu học Việt Nam” Imbalance in immune cells causes hair loss in alopecia areata.
March 2026 in “JMIR Dermatology” Interest in JAK inhibitors for alopecia areata increased significantly after FDA approval, highlighting the need for patient education.
March 2026 in “International journal of Nutrition Pharmacology Neurological Diseases” Hair loss is common but often untreated in Saudi Arabia, needing more public awareness and better access to care.
March 2026 in “Skin Appendage Disorders” Belatacept may be a promising treatment for alopecia areata.
CD28 is a promising target for treating alopecia areata with belatacept.
CD28 is a promising target for treating alopecia areata with belatacept.